Cargando…

Lipid Based Therapy for Ulcerative Colitis—Modulation of Intestinal Mucus Membrane Phospholipids as a Tool to Influence Inflammation

Ulcerative colitis (UC) is the result of an inappropriate colonic inflammatory response triggered by environmental and genetic factors. We have recently shown that mucus from UC patients has a decreased phosphatidylcholine (PC) content, while clinical trials revealed that therapeutic addition of PC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schneider, Hannah, Braun, Annika, Füllekrug, Joachim, Stremmel, Wolfgang, Ehehalt, Robert
Formato:	Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International (MDPI) 2010
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2996791/ https://www.ncbi.nlm.nih.gov/pubmed/21152327 http://dx.doi.org/10.3390/ijms11104149

Ejemplares similares

TNF-α-induced up-regulation of pro-inflammatory cytokines is reduced by phosphatidylcholine in intestinal epithelial cells
por: Treede, Irina, et al.
Publicado: (2009)

Transcript levels of different cytokines and chemokines correlate with clinical and endoscopic activity in ulcerative colitis
por: Zahn, Alexandra, et al.
Publicado: (2009)

Uptake of long chain fatty acids is regulated by dynamic interaction of FAT/CD36 with cholesterol/sphingolipid enriched microdomains (lipid rafts)
por: Ehehalt, Robert, et al.
Publicado: (2008)

Overexpression of CD36 and Acyl-CoA Synthetases FATP2, FATP4 and ACSL1 Increases Fatty Acid Uptake in Human Hepatoma Cells
por: Krammer, Julia, et al.
Publicado: (2011)

Genetic Mouse Models with Intestinal-Specific Tight Junction Deletion Resemble an Ulcerative Colitis Phenotype
por: Stremmel, Wolfgang, et al.
Publicado: (2017)

Outlook: membrane junctions enable the metabolic trapping of fatty acids by intracellular acyl-CoA synthetases
por: Füllekrug, Joachim, et al.
Publicado: (2012)

Slimy partners: the mucus barrier and gut microbiome in ulcerative colitis
por: Fang, Jian, et al.
Publicado: (2021)

Oxidized phospholipids cause changes in jejunum mucus that induce dysbiosis and systemic inflammation
por: Mukherjee, Pallavi, et al.
Publicado: (2021)

Overexpressed FATP1, ACSVL4/FATP4 and ACSL1 Increase the Cellular Fatty Acid Uptake of 3T3-L1 Adipocytes but Are Localized on Intracellular Membranes
por: Zhan, Tianzuo, et al.
Publicado: (2012)

Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis
por: van der Post, Sjoerd, et al.
Publicado: (2019)

Mucus-Penetrating Silk Fibroin-Based Nanotherapeutics for Efficient Treatment of Ulcerative Colitis
por: Xie, Dengchao, et al.
Publicado: (2022)

Flotillin-2 Expression in the Human Gut: from a Cell Model to Human Tissue in Health and Inflammatory Bowel Diseases
por: Gauss, Annika, et al.
Publicado: (2013)

A15 GENETIC OR DIET-ASSOCIATED DEFECTS IN MUCUS FACILITATE ULCERATIVE COLITIS PATHOBIONT-DRIVEN COLITIS
por: Yang, H, et al.
Publicado: (2023)

Lipids alter microbial transport through intestinal mucus
por: Carlson, Taylor L., et al.
Publicado: (2018)

Quality of Life Is Related to Fecal Calprotectin Concentrations in Colonic Crohn Disease and Ulcerative Colitis, but not in Ileal Crohn Disease
por: Gauss, Annika, et al.
Publicado: (2016)

Colonisation of the colonic mucus gel layer with butyrogenic and hydrogenotropic bacteria in health and ulcerative colitis
por: Earley, Helen, et al.
Publicado: (2021)

Bacteria penetrate the normally impenetrable inner colon mucus layer in both murine colitis models and patients with ulcerative colitis
por: Johansson, Malin E V, et al.
Publicado: (2014)

A Novel Nomogram Combining Mucus Barrier Index for Predicting Treatment Failures in Ulcerative Colitis
por: Wang, Ying, et al.
Publicado: (2023)

The Bile Acid-Phospholipid Conjugate Ursodeoxycholyl-Lysophosphatidylethanolamide (UDCA-LPE) Disintegrates the Lipid Backbone of Raft Plasma Membrane Domains by the Removal of the Membrane Phospholipase A2
por: Stremmel, Wolfgang, et al.
Publicado: (2019)

Extraintestinal pathogenic Escherichia coli are associated with intestinal inflammation in patients with ulcerative colitis
por: Mirsepasi-Lauridsen, Hengameh C., et al.
Publicado: (2016)

Fate of paclitaxel lipid nanocapsules in intestinal mucus in view of their oral delivery
por: Groo, Anne-Claire, et al.
Publicado: (2013)

Intestinal Ultrasonography as a Tool for Monitoring Disease Activity in Patients with Ulcerative Colitis
por: Stojkovic Lalosevic, Milica, et al.
Publicado: (2022)

Comparative study of mucoadhesive and mucus-penetrative nanoparticles based on phospholipid complex to overcome the mucus barrier for inhaled delivery of baicalein
por: Dong, Wujun, et al.
Publicado: (2020)

Comparative study between histochemical mucus volume, histopathological findings, and endocytoscopic scores in patients with ulcerative colitis
por: Kamitani, Yu, et al.
Publicado: (2023)

The neglected biliary mucus and its phosphatidylcholine content: a putative player in pathogenesis of primary cholangitis—a narrative review article
por: Stremmel, Wolfgang, et al.
Publicado: (2021)

Intestinal Giardiasis Disguised as Ulcerative Colitis
por: Zhen, Yu, et al.
Publicado: (2018)

Bacteria Penetrate the Inner Mucus Layer before Inflammation in the Dextran Sulfate Colitis Model
por: Johansson, Malin E. V., et al.
Publicado: (2010)

Maltodextrin Consumption Impairs the Intestinal Mucus Barrier and Accelerates Colitis Through Direct Actions on the Epithelium
por: Zangara, Megan T., et al.
Publicado: (2022)

Bifidobacterium and the intestinal mucus layer
por: Gutierrez, Alyssa, et al.
Publicado: (2023)

Contribution of NOTCH signaling pathway along with TNF-α in the intestinal inflammation of ulcerative colitis
por: Ghorbaninejad, Mahsa, et al.
Publicado: (2019)

Irisin attenuates inflammation in a mouse model of ulcerative colitis by altering the intestinal microbiota
por: Huangfu, Lu Xin, et al.
Publicado: (2021)

Artemisinin Alleviates Intestinal Inflammation and Metabolic Disturbance in Ulcerative Colitis Rats Induced by DSS
por: Jia, Xuemei, et al.
Publicado: (2022)

Lycopene, Lutein and Zeaxanthin May Reduce Faecal Blood, Mucus and Pus but not Abdominal Pain in Individuals with Ulcerative Colitis
por: Głąbska, Dominika, et al.
Publicado: (2016)

Metformin Exerts Anti-inflammatory and Mucus Barrier Protective Effects by Enriching Akkermansia muciniphila in Mice With Ulcerative Colitis
por: Ke, Haoran, et al.
Publicado: (2021)

Fatty Acid- and Cholesterol Transporter Protein Expression along the Human Intestinal Tract
por: Masson, Christiaan J., et al.
Publicado: (2010)

Interactions of Intestinal Bacteria with Components of the Intestinal Mucus
por: Sicard, Jean-Félix, et al.
Publicado: (2017)

Cell surface‐anchored syndecan‐1 ameliorates intestinal inflammation and neutrophil transmigration in ulcerative colitis
por: Zhang, Yan, et al.
Publicado: (2016)

Anti-commensal IgG Drives Intestinal Inflammation and Type 17 Immunity in Ulcerative Colitis
por: Castro-Dopico, Tomas, et al.
Publicado: (2019)

Unconjugated bilirubin alleviates experimental ulcerative colitis by regulating intestinal barrier function and immune inflammation
por: Zheng, Jia-Dong, et al.
Publicado: (2019)

Leonurine protects against ulcerative colitis by alleviating inflammation and modulating intestinal microflora in mouse models
por: Zheng, Suna, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_3kp3jjkogej3o45ci5a79aikih